Palvella Therapeutics (PVLA) Receivables - Net (2016 - 2024)
Historic Receivables - Net for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to $373000.0.
- Palvella Therapeutics' Receivables - Net fell 6430.62% to $373000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $373000.0, marking a year-over-year decrease of 6430.62%. This contributed to the annual value of $5.8 million for FY2022, which is 6582.35% down from last year.
- Per Palvella Therapeutics' latest filing, its Receivables - Net stood at $373000.0 for Q3 2024, which was down 6430.62% from $1.5 million recorded in Q2 2024.
- Palvella Therapeutics' Receivables - Net's 5-year high stood at $17.0 million during Q2 2021, with a 5-year trough of $373000.0 in Q3 2024.
- Its 5-year average for Receivables - Net is $4.5 million, with a median of $1.8 million in 2020.
- In the last 5 years, Palvella Therapeutics' Receivables - Net soared by 12574.73% in 2021 and then plummeted by 9256.47% in 2022.
- Palvella Therapeutics' Receivables - Net (Quarter) stood at $1.7 million in 2020, then soared by 94.2% to $3.3 million in 2021, then soared by 75.37% to $5.8 million in 2022, then tumbled by 82.01% to $1.0 million in 2023, then plummeted by 64.31% to $373000.0 in 2024.
- Its Receivables - Net stands at $373000.0 for Q3 2024, versus $1.5 million for Q2 2024 and $1.8 million for Q1 2024.